Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-008096
Filing Date
2025-05-01
Accepted
2025-05-01 16:05:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 928801
2 GRAPHIC form424b3_001.jpg GRAPHIC 15339
  Complete submission text file 0001641172-25-008096.txt   951212
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286754 | Film No.: 25903007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)